FDA & Healthcare partner Stephen Mahinka will moderating a panel "Risk Management: A 360° View" at the US-Japan Health Sciences Dialogue.
Risk and risk management, the theme of the 12th Annual US-Japan Health Sciences Dialogue, has many different implications in the world of drug development and commercialization. Indeed, risk management is an increasingly international and evolving factor in every decision and at every stage of development. The 2012 Health Sciences Dialogue will focus on "risk management" as practiced today and whether that may actually hinder the growth of the biopharmaceutical sector. This panel will set the stage for the discussions that will follow.
Tuesday, November 27, 2012
9:15-10:30 am ET